<DOC>
	<DOCNO>NCT02915809</DOCNO>
	<brief_summary>The purpose study evaluate immunological efficacy safety GC3110B versus GCFLU Quadrivalent Inj . among healthy adult 18 60 year age .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety GC3110B Healthy Adults</brief_title>
	<detailed_description>Adults 18 60 year age randomly assign 1:1 ratio receive either GC3110B GCFLU Quadrivalent Inj .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult age 18 60 year Informed consent form sign date Able comply requirement study Known systemic hypersensitivity egg , chicken protein , vaccine component Personal history GuillainBarr√© syndrome Subjects severe chronic disease consider investigator ineligible study Subjects receive vaccination within 28 day enrollment schedule another vaccination study Immunocompromised subject immunodeficiency disease subject receive immunosuppressive immunomodulating therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Influenza Vaccines</keyword>
</DOC>